ADD ANI AS A TRUSTED SOURCE
googleads
ANI Logo
Menu
Science

Study finds how ultrasound is effective in diagnosing specific breast symptoms

According to a study, ultrasound works well as a stand-alone diagnostic technique for patients with specific breast symptoms

ANI Apr 05, 2023 00:12 IST googleads

Representative Image

Illinois [United States], April 5 (ANI): According to a study, ultrasound works well as a stand-alone diagnostic technique for patients with specific breast symptoms. Focal breast complaints can relate to symptoms and conditions that are limited to a particular location of the breast, such as pain, tumours, nipple discharge, or other symptoms.
The findings of the study published in the Radiology, a publication of the Radiological Society of North America,
In women, focal breast complaints are a frequent problem. In the Netherlands, approximately 70,000 women visit radiology departments annually with focal breast complaints. The most common being the presence of lumps or pain. Many women who have focal breast complaints are between the ages of 30 and 50 years.
Digital breast tomosynthesis (DBT) followed by targeted ultrasound is the standard diagnostic tool for women 30 years or older with localized breast complaints. While DBT provides an overall image of both breasts, ultrasound can achieve more targeted imaging of a specific area of the breast. The quality of ultrasound images has also vastly improved in recent years.
For the new study, researchers set out to investigate the performance of ultrasound alone as an effective diagnostic method in women over the age of 30 who reported localized breast complaints at three hospitals in the Netherlands between September 2017 and June 2019.
"The evaluation of breast complaints is a common problem in breast diagnostics," said study co-author Linda Appelman, M.D., a breast radiologist in the Department of Medical Imaging at Radboud University Medical Center in Nijmegen, the Netherlands. "Ultrasound as the first imaging method may provide clarity with regard to the focal breast complaint."
Breast lumps or localized breast pain were two of the most common symptoms reported by the 1,961 women included in the study. A total of seven subgroups of focal complaints were recognized.
In all patients, targeted ultrasound was evaluated first, followed by DBT. Biopsy was performed after ultrasound, if needed. Since the ultrasounds were conducted first, the radiologists who participated in the study weren't influenced by the DBT images when interpreting the ultrasounds.
Analysis showed that ultrasound alone led to accurate diagnosis in 1,759 (90%) of the 1,961 patients. Over 80% of the complaints ended up being normal or benign findings, such as cysts.
"We found that the diagnostic accuracy of ultrasound is high in women with focal breast complaints," Dr. Appelman said.
A total of 374 patients had biopsies based on ultrasound findings alone. This resulted in 192 symptomatic breast cancer diagnoses.
Ultrasound of focal breast complaints may be especially beneficial in low- or middle-income countries where ultrasound is more readily available as opposed to DBT.
"Our study showed that ultrasound alone can effectively diagnose focal breast complaints in a large majority of women," Dr. Appelman said. "In a setting with limited resources or an already existing screening program, initial ultrasound might be a better alternative compared to mammography."
The cost effectiveness of ultrasound and the improved patient comfort during the procedure are other factors to consider when expanding its implementation in symptomatic breast cancer diagnosis. (ANI)

Get the App

What to Read Next

Science

New insights into how cancer evades the immune system: Study

New insights into how cancer evades the immune system: Study

Immunotherapy research primarily focuses on better recognition of cancer cells by the body's own immune system. Researchers at Amsterdam UMC and Moffitt Cancer Center have taken a different approach.

Read More
Science

Strand Life Sciences launches portal for rare disease diagnosis

Strand Life Sciences launches portal for rare disease diagnosis

Marking Rare Disease Day, Strand Life Sciences, a subsidiary of Reliance Industries and a leading genomics research company, has launched the StrandOmics Portal, an innovative digital platform designed to assist doctors in diagnosing rare diseases more efficiently.

Read More
Science

COVID-19 severity may be predicted by White Blood Cell Count

COVID-19 severity may be predicted by White Blood Cell Count

A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a new study reveals that leukocyte (white blood cell) count may now be used to identify who is more likely to develop more significant disease symptoms.

Read More
Science

Cancer cells of fat may enhance cancer treatment

Cancer cells of fat may enhance cancer treatment

A study by Van Andel Institute scientists suggests that restricting cancer cells' access to fat may enhance the effectiveness of certain cancer treatments.

Read More
Science

Biomarker may predict response to immunotherapy in liver cancer

Biomarker may predict response to immunotherapy in liver cancer

According to a preclinical study conducted by Weill Cornell Medicine researchers, it may soon be feasible to detect whether individuals with hepatocellular carcinoma, a kind of liver cancer, may benefit from immunotherapy.

Read More
Science

Bacterial vaccine demonstrates potential as cancer treatment

Bacterial vaccine demonstrates potential as cancer treatment

Columbia researchers developed probiotic bacteria that train the immune system to eliminate cancer cells, paving the way for a new class of cancer vaccinations that take advantage of bacteria's innate tumour-targeting abilities. These microbial cancer vaccines can be tailored to each person's specific original tumour and metastases, perhaps preventing future recurrences.

Read More
Science

Alternate method to study changes during DNA replication process

Alternate method to study changes during DNA replication process

Researchers at Colorado State University discovered an alternative way for studying alterations during the DNA replication process in lab settings using genetically modified yeast. The novel methodology provides a clearer picture than current pharmacological methods for understanding cell cycle arrest, a fundamental mechanism critical to cancer treatment and genetic concerns.

Read More
Science

Study discovers how special immune cells stop metastatic cancer

Study discovers how special immune cells stop metastatic cancer

The majority of cancer deaths are caused by metastatic disease, which occurs when cancer spreads from the primary tumour to other areas of the body. and researchers understand how cancer cells escape the primary location to seed new tumours, it is unclear why some cancer cells produce new tumours decades later and others do not.

Read More
Science

Study reveals role of gamma-delta T cells in cancer immunology

Study reveals role of gamma-delta T cells in cancer immunology

The significance of gamma-delta T cells in 33 different cancer types is revealed in a recent study that was published in Cell Press. This information sheds light on the cells' potential as clinical biomarkers and therapeutic targets in the treatment of cancer. This thorough examination, which was carried out under the direction of a group of Moffitt Cancer Center experts, marks a substantial breakthrough in our knowledge of these distinct immune cells and how they affect cancer therapy outcomes for patients.

Read More
Science

Medication increases radiation therapy's efficacy for lung cancer

Medication increases radiation therapy's efficacy for lung cancer

A group of researchers from the University of Cincinnati has discovered a possible novel approach to enhance the efficacy of radiation therapy and enhance the prognosis of patients with lung cancer metastasizing to the brain.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.